TechnologyJuly 27, 2026
Major Breakthrough in Cell Therapy Technology
Our R&D team achieved a key technological breakthrough in cell therapy.
CompanyJuly 27, 2026
Huayuu Biopharma Completes Series B Funding
The company successfully completed Series B funding of 500 million RMB.
IndustryJuly 27, 2026
Huayu Invited to 2026 Biopharma Industry Forum
Our CEO was invited to speak at the industry forum.

